We are live on
!
Find out more
MC
Muhlenkamp & Co Portfolio holdings
AUM
$380M
1-Year Est. Return
43.74%
This Fund
S&P 500
This Quarter
Est. Return
+12.96%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$270M
AUM Growth
+$21.9M
(+8.8%)
Cap. Flow
-$21.6M
Cap. Flow
% of AUM
-7.99%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
38
New
1
Increased
18
Reduced
12
Closed
5
Top Buys
| 1 |
SLB Ltd
SLB
|
+$3.45M |
| 2 |
EQC
Equity Commonwealth
EQC
|
+$1.08M |
| 3 |
Alerian MLP ETF
AMLP
|
+$664K |
| 4 |
Royal Gold
RGLD
|
+$472K |
| 5 |
Franco-Nevada
FNV
|
+$420K |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$8.33M |
| 2 |
Baidu
BIDU
|
+$5.85M |
| 3 |
MasTec
MTZ
|
+$3.26M |
| 4 |
Gilead Sciences
GILD
|
+$2.96M |
| 5 |
Lennar Class A
LEN
|
+$2.17M |
Sector Composition
| 1 | Technology | 18.7% |
| 2 | Healthcare | 18.22% |
| 3 | Industrials | 17.47% |
| 4 | Consumer Discretionary | 15.34% |
| 5 | Financials | 11.21% |
Similar funds
AC
MW
EAM
RWA
CSWG
BP
NICM
KFS
Muhlenkamp & Co's Q1 2021 Portfolio in Review
As of Q1 2021, Muhlenkamp & Co held 38 positions worth $270M, up 8.8% from $248M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Muhlenkamp & Co withdrew a net $21.6M in Q1 2021, closing 5 positions and reducing 12 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $8.33M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Muhlenkamp & Co opened a new position in Equity Commonwealth worth $1.01M.
- Muhlenkamp & Co's largest Q1 2021 buy was Equity Commonwealth: 38,348 shares worth $1.01M.
- Muhlenkamp & Co added most to SLB Ltd in Q1 2021, an estimated $3.45M increase.
- Muhlenkamp & Co's biggest Q1 2021 reduction was MasTec, cutting an estimated $3.26M.
- Muhlenkamp & Co fully exited Jazz Pharmaceuticals in Q1 2021, selling an estimated $8.33M.
- Muhlenkamp & Co's ten largest holdings make up 48% of its $270M portfolio in Q1 2021.
- Muhlenkamp & Co opened 1 new position and closed 5 in Q1 2021.
- Muhlenkamp & Co's portfolio value rose 8.8% quarter-over-quarter to $270M.
Based on Muhlenkamp & Co's 13F filing for Q1 2021, filed 18 Aug 2021.